Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Neuroblastoma 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Cyclophosphamide 7Antilymphocyte Serum 7fludarabine phosphate 6Rituximab 6Filgrastim 6romidepsin 5Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Flow Cytometry 5Vorinostat 4Tacrolimus 4Gemcitabine 4Etoposide 4Cyclosporine 4Busulfan 4Bortezomib 4tanespimycin 3belinostat 3Whole-Body Irradiation 3Methylprednisolone 3Methotrexate 3Melphalan 3Lenalidomide 3Cord Blood Stem Cell Transplantation 3plerixafor 2nelarabine 2cobomarsen 2carfilzomib 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoma, T-Cell, Cutaneous × Interleukin-12 Subunit p35 × Clear all
NCT00052377 2013-01-16

Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides

National Cancer Institute (NCI)

Phase 1/2 Terminated
46 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡